Clinuvel Pharmaceuticals Limited ( CLVLY) - Key Metrics
CLVLY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.74 | $0.21 | $0.25 | $0.25 |
| 2025Q4 | $1.19 | $0.44 | $0.56 | $0.55 |
| 2025Q2 | $0.71 | $0.28 | $0.26 | $0.26 |
| 2024Q4 | $1.10 | $0.49 | $0.21 | $0.21 |
| 2024Q2 | $0.64 | $0.22 | $0.53 | $0.42 |
CLVLY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 24.00% | 14.96 |
| 2025Q4 | 0.00% | 5.88 |
| 2025Q2 | 17.79% | 10.77 |
| 2024Q4 | ? | 7.81 |
| 2024Q2 | 22.59% | 18.33 |
CLVLY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.98% | 0.40% |
| 2025Q4 | 5.33% | 0.00% |
| 2025Q2 | 2.16% | 0.41% |
| 2024Q4 | 1.35% | ? |
| 2024Q2 | 2.63% | 0.31% |
CLVLY
Price: $6.26
Dividend Yield: 0.45%
Forward Dividend Yield: 0.53%
Payout Ratio: 7.24%
Dividend Per Share: 0.03 USD
Earnings Per Share: 0.45 USD
P/E Ratio: 15.58
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Market Capitalization: 333.5 million
Average Dividend Frequency: 1
Years Paying Dividends: 8
DGR3: 7.22%
DGR5: 14.28%